CFDE Data Portal | Search CENPNP1

	Label	Description
	CENPNP1 Gene (Entity type)	ENSG00000233671 - CENPN pseudogene 1
	GSE252944 AKT inhibition 10 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE132953 Znf148 knockdown MDA-MB-231 RNA Small Interfering 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 5 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE253554 CHRDL2 overexpression Caco-2 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

CENPNP1

ENSG00000233671 - CENPN pseudogene 1

GSE252944 AKT inhibition 10 v 15 human up

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 5 human up

A Gene Set from LINCS

GSE132953 Znf148 knockdown MDA-MB-231 RNA Small Interfering 0 v 1 human dn

A Gene Set from LINCS

GSE239844 crizotinib 4 v 5 human dn

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 3 human up

A Gene Set from LINCS

GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human dn

A Gene Set from LINCS

GSE233679 nicotinamide 5 v 11 human up

A Gene Set from LINCS

GSE253554 CHRDL2 overexpression Caco-2 0 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.